{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T02:44:23Z","timestamp":1795056263917,"version":"4.10.2"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Q fever is an infectious zoonotic disease, caused by the Gram-negative bacterium <jats:italic>Coxiella burnetii<\/jats:italic>. Transmission occurs from livestock to humans through inhalation of a survival form of the bacterium, the Small Cell Variant, often via handling of animal parturition products. Q fever manifests as an acute self-limiting febrile illness or as a chronic disease with complications such as vasculitis and endocarditis. The current preventative human Q fever vaccine Q-VAX poses limitations on its worldwide implementation due to reactogenic responses in pre-sensitized individuals. Many strategies have been undertaken to develop a universal Q fever vaccine but with little success to date. The mechanisms of the underlying reactogenic responses remain only partially understood and are important factors in the development of a safe Q fever vaccine. This review provides an overview of previous and current experimental vaccines developed for use against Q fever and proposes approaches to develop a vaccine that establishes immunological memory while eliminating harmful reactogenic responses.<\/jats:p>","DOI":"10.1038\/s41541-023-00727-6","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T19:01:51Z","timestamp":1694113311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Q fever immunology: the quest for a safe and effective vaccine"],"prefix":"10.1038","volume":"8","author":[{"given":"Gayathri","family":"Sam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5465-2926","authenticated-orcid":false,"given":"John","family":"Stenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3908-8903","authenticated-orcid":false,"given":"Bernd H. A.","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"727_CR1","doi-asserted-by":"crossref","unstructured":"Derrick, E. \u201cQ\u201d fever, a new fever entity: clinical features, diagnosis and laboratory investigation. Med. J. Aust. 2, 281\u2013299 (1937).","DOI":"10.5694\/j.1326-5377.1937.tb43743.x"},{"key":"727_CR2","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2307\/4582746","volume":"53","author":"GE Davis","year":"1938","unstructured":"Davis, G. E. et al. A filter-passing infectious agent isolated from ticks. Public Health Rep. 53, 2259\u20132311 (1938).","journal-title":"Public Health Rep."},{"key":"727_CR3","doi-asserted-by":"crossref","unstructured":"Cox, H. R. & Beli, E. J. The cultivation of Rickettsia diaporica in tissue culture and in the tissues of developing chick embryos. Public Health Rep. 54, 2171\u20132178 (1939).","DOI":"10.2307\/4583112"},{"key":"727_CR4","doi-asserted-by":"crossref","unstructured":"Cutler, S. J. Bacteria: Coxiella burnetii. In Encyclopedia of Food Safety (ed. Motarjemi, Y.) 410\u2013416 (Academic Press, 2014).","DOI":"10.1016\/B978-0-12-378612-8.00094-9"},{"key":"727_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.micinf.2019.09.001","volume":"22","author":"AL Dragan","year":"2020","unstructured":"Dragan, A. L. & Voth, D. E. Coxiella burnetii: international pathogen of mystery. Microbes Infect. 22, 100\u2013110 (2020).","journal-title":"Microbes Infect."},{"key":"727_CR6","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/microorganisms10081530","volume":"10","author":"Q Ullah","year":"2022","unstructured":"Ullah, Q. et al. Q fever\u2014a neglected zoonosis. Microorganisms 10, 1530 (2022).","journal-title":"Microorganisms"},{"key":"727_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1128\/CMR.00045-16","volume":"30","author":"C Eldin","year":"2017","unstructured":"Eldin, C. et al. From Q fever to Coxiella burnetii Infection: a paradigm change. Clin. Microbiol. Rev. 30, 115\u2013190 (2017).","journal-title":"Clin. Microbiol. Rev."},{"key":"727_CR8","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1128\/iai.55.5.1144-1150.1987","volume":"55","author":"A Moos","year":"1987","unstructured":"Moos, A. & Hackstadt, T. Comparative virulence of intra-and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Infect. Immun. 55, 1144\u20131150 (1987).","journal-title":"Infect. Immun."},{"key":"727_CR9","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.jinf.2015.04.024","volume":"71","author":"M Million","year":"2015","unstructured":"Million, M. & Raoult, D. Recent advances in the study of Q fever epidemiology, diagnosis and management. J. Infect. 71, S2\u2013S9 (2015).","journal-title":"J. Infect."},{"key":"727_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.5694\/mja2.13004","volume":"210","author":"HF Gidding","year":"2019","unstructured":"Gidding, H. F. et al. Seroprevalence of Q fever among metropolitan and non-metropolitan blood donors in New South Wales and Queensland, 2014-2015. Med. J. Aust. 210, 309\u2013315 (2019).","journal-title":"Med. J. Aust."},{"key":"727_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1467-842X.1997.tb01787.x","volume":"21","author":"MG Garner","year":"1997","unstructured":"Garner, M. G. et al. A review of Q fever in Australia 1991\u20131994. Aust. N.Z. J. Public Health 21, 722\u2013730 (1997).","journal-title":"Aust. N.Z. J. Public Health"},{"key":"727_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/S0950268811000136","volume":"140","author":"B Schimmer","year":"2012","unstructured":"Schimmer, B. et al. Low seroprevalence of Q fever in the Netherlands prior to a series of large outbreaks. Epidemiol. Infect. 140, 27\u201335 (2012).","journal-title":"Epidemiol. Infect."},{"key":"727_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/mic.0.000707","volume":"165","author":"EI Shaw","year":"2019","unstructured":"Shaw, E. I. & Voth, D. E. Coxiella burnetii: a pathogenic intracellular acidophile. Microbiology 165, 1\u20133 (2019).","journal-title":"Microbiology"},{"key":"727_CR14","doi-asserted-by":"publisher","first-page":"754455","DOI":"10.3389\/fcimb.2021.754455","volume":"11","author":"G Sireci","year":"2021","unstructured":"Sireci, G. et al. Recent advances on the innate immune response to Coxiella burnetii. Front. Cell Infect. Microbiol. 11, 754455 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"727_CR15","doi-asserted-by":"publisher","first-page":"e0041022","DOI":"10.1128\/iai.00410-22","volume":"90","author":"D Park","year":"2022","unstructured":"Park, D. et al. Developmental transitions coordinate assembly of the Coxiella burnetii Dot\/Icm type IV secretion system. Infect. Immun. 90, e0041022 (2022).","journal-title":"Infect. Immun."},{"key":"727_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1196\/annals.1355.026","volume":"1063","author":"M Andoh","year":"2005","unstructured":"Andoh, M. et al. Comparative virulence of phase I and II Coxiella burnetii in immunodeficient mice. Ann. N. Y. Acad. Sci. 1063, 167\u2013170 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"727_CR17","doi-asserted-by":"publisher","first-page":"101903","DOI":"10.1016\/j.jbc.2022.101903","volume":"298","author":"AR Cross","year":"2022","unstructured":"Cross, A. R. et al. Spinning sugars in antigen biosynthesis: characterization of the Coxiella burnetii and Streptomyces griseus TDP-sugar epimerases. J. Biol. Chem. 298, 101903 (2022).","journal-title":"J. Biol. Chem."},{"key":"727_CR18","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3390\/vaccines10091393","volume":"10","author":"SR Graves","year":"2022","unstructured":"Graves, S. R. et al. An O-specific polysaccharide\/tetanus toxoid conjugate vaccine induces protection in guinea pigs against virulent challenge with Coxiella burnetii. Vaccines 10, 1393 (2022).","journal-title":"Vaccines"},{"key":"727_CR19","doi-asserted-by":"publisher","first-page":"e1006922","DOI":"10.1371\/journal.ppat.1006922","volume":"14","author":"PA Beare","year":"2018","unstructured":"Beare, P. A. et al. Genetic mechanisms of Coxiella burnetii lipopolysaccharide phase variation. PLoS Pathog. 14, e1006922 (2018).","journal-title":"PLoS Pathog."},{"key":"727_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00296-6","volume":"6","author":"CM Long","year":"2021","unstructured":"Long, C. M. et al. Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity. NPJ Vaccines 6, 38 (2021).","journal-title":"NPJ Vaccines"},{"key":"727_CR21","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fmicb.2014.00726","volume":"5","author":"S Ruiz","year":"2014","unstructured":"Ruiz, S. & Wolfe, D. N. Vaccination against Q fever for biodefense and public health indications. Front. Microbiol. 5, 726 (2014).","journal-title":"Front. Microbiol."},{"key":"727_CR22","doi-asserted-by":"crossref","unstructured":"Miller, J., Shaw, E. & Thompson, H. Coxiella burnetii, Q fever, and bioterrorism. In Microorganisms and Bioterrorism (eds Anderson, B., Friedman, H. & Bendinelli, M.). 181\u2013208 (Springer, 2006).","DOI":"10.1007\/0-387-28159-2_10"},{"key":"727_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0733-8627(01)00002-5","volume":"20","author":"DL Noah","year":"2002","unstructured":"Noah, D. L. et al. The history and threat of biological warfare and terrorism. Emerg. Med. Clin. 20, 255\u2013271 (2002).","journal-title":"Emerg. Med. Clin."},{"key":"727_CR24","doi-asserted-by":"publisher","first-page":"13708","DOI":"10.1073\/pnas.1914892117","volume":"117","author":"M Burette","year":"2020","unstructured":"Burette, M. et al. Modulation of innate immune signaling by a Coxiella burnetii eukaryotic-like effector protein. Proc. Natl Acad. Sci. USA 117, 13708\u201313718 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"727_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrmicro3049","volume":"11","author":"EJ van Schaik","year":"2013","unstructured":"van Schaik, E. J. et al. Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii. Nat. Rev. Microbiol. 11, 561\u2013573 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"727_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1462-5822.2007.00901.x","volume":"9","author":"DE Voth","year":"2007","unstructured":"Voth, D. E. & Heinzen, R. A. Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii. Cell Microbiol. 9, 829\u2013840 (2007).","journal-title":"Cell Microbiol."},{"key":"727_CR27","doi-asserted-by":"publisher","first-page":"e39348","DOI":"10.1371\/journal.pone.0039348","volume":"7","author":"EM Rosales","year":"2012","unstructured":"Rosales, E. M. et al. Cortactin is involved in the entry of Coxiella burnetii into non-phagocytic cells. PLoS ONE 7, e39348 (2012).","journal-title":"PLoS ONE"},{"key":"727_CR28","doi-asserted-by":"publisher","first-page":"e1004013","DOI":"10.1371\/journal.ppat.1004013","volume":"10","author":"E Martinez","year":"2014","unstructured":"Martinez, E. et al. Identification of OmpA, a Coxiella burnetii protein involved in host cell invasion, by multi-phenotypic high-content screening. PLoS Pathog. 10, e1004013 (2014).","journal-title":"PLoS Pathog."},{"key":"727_CR29","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.4049\/jimmunol.163.11.6078","volume":"163","author":"C Capo","year":"1999","unstructured":"Capo, C. et al. Subversion of monocyte functions by Coxiella burnetii: impairment of the cross-talk between \u03b1v\u03b23 integrin and CR3. J. Immunol. 163, 6078\u20136085 (1999).","journal-title":"J. Immunol."},{"key":"727_CR30","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.4049\/jimmunol.170.8.4217","volume":"170","author":"C Capo","year":"2003","unstructured":"Capo, C. et al. Coxiella burnetii avoids macrophage phagocytosis by interfering with spatial distribution of complement receptor 3. J. Immunol. 170, 4217\u20134225 (2003).","journal-title":"J. Immunol."},{"key":"727_CR31","doi-asserted-by":"publisher","first-page":"7288","DOI":"10.1016\/j.vaccine.2007.08.002","volume":"25","author":"DM Waag","year":"2007","unstructured":"Waag, D. M. Coxiella burnetii: host and bacterial responses to infection. Vaccine 25, 7288\u20137295 (2007).","journal-title":"Vaccine"},{"key":"727_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1128\/iai.56.1.40-44.1988","volume":"56","author":"S Vishwanath","year":"1988","unstructured":"Vishwanath, S. & Hackstadt, T. Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii. Infect. Immun. 56, 40\u201344 (1988).","journal-title":"Infect. Immun."},{"key":"727_CR33","doi-asserted-by":"publisher","first-page":"e0145211","DOI":"10.1371\/journal.pone.0145211","volume":"10","author":"RP Salinas","year":"2015","unstructured":"Salinas, R. P. et al. Coxiella burnetii phagocytosis is regulated by GTPases of the Rho family and the RhoA effectors mDia1 and ROCK. PLoS ONE 10, e0145211 (2015).","journal-title":"PLoS ONE"},{"key":"727_CR34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrm2515","volume":"9","author":"JM Kinchen","year":"2008","unstructured":"Kinchen, J. M. & Ravichandran, K. S. Phagosome maturation: going through the acid test. Nat. Rev. Mol. Cell Biol. 9, 781\u2013795 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"727_CR35","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3389\/fimmu.2020.01066","volume":"11","author":"E Uribe-Querol","year":"2020","unstructured":"Uribe-Querol, E. & Rosales, C. Phagocytosis: our current understanding of a universal biological process. Front. Immunol. 11, 1066 (2020).","journal-title":"Front. Immunol."},{"key":"727_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.it.2012.03.003","volume":"33","author":"GD Fairn","year":"2012","unstructured":"Fairn, G. D. & Grinstein, S. How nascent phagosomes mature to become phagolysosomes. Trends Immunol. 33, 397\u2013405 (2012).","journal-title":"Trends Immunol."},{"key":"727_CR37","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.4049\/jimmunol.169.8.4488","volume":"169","author":"E Ghigo","year":"2002","unstructured":"Ghigo, E. et al. Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation: IFN-gamma mediates its restoration and bacterial killing. J. Immunol. 169, 4488\u20134495 (2002).","journal-title":"J. Immunol."},{"key":"727_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1462-5822.2005.00527.x","volume":"7","author":"MG Gutierrez","year":"2005","unstructured":"Gutierrez, M. G. et al. Autophagy induction favours the generation and maturation of the Coxiella-replicative vacuoles. Cell Microbiol. 7, 981\u2013993 (2005).","journal-title":"Cell Microbiol."},{"key":"727_CR39","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1462-5822.2005.00641.x","volume":"8","author":"D Howe","year":"2006","unstructured":"Howe, D. & Heinzen, R. A. Coxiella burnetii inhabits a cholesterol-rich vacuole and influences cellular cholesterol metabolism. Cell Microbiol. 8, 496\u2013507 (2006).","journal-title":"Cell Microbiol."},{"key":"727_CR40","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1462-5822.2006.00838.x","volume":"9","author":"PS Romano","year":"2007","unstructured":"Romano, P. S. et al. The autophagic pathway is actively modulated by phase II Coxiella burnetii to efficiently replicate in the host cell. Cell Microbiol. 9, 891\u2013909 (2007).","journal-title":"Cell Microbiol."},{"key":"727_CR41","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1128\/IAI.70.10.5816-5821.2002","volume":"70","author":"W Beron","year":"2002","unstructured":"Beron, W. et al. Coxiella burnetii localizes in a Rab7-labeled compartment with autophagic characteristics. Infect. Immun. 70, 5816\u20135821 (2002).","journal-title":"Infect. Immun."},{"key":"727_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature09782","volume":"469","author":"B Levine","year":"2011","unstructured":"Levine, B., Mizushima, N. & Virgin, H. W. Autophagy in immunity and inflammation. Nature 469, 323\u2013335 (2011).","journal-title":"Nature"},{"key":"727_CR43","doi-asserted-by":"publisher","first-page":"e01127-16","DOI":"10.1128\/mBio.01127-16","volume":"7","author":"LJ Kohler","year":"2016","unstructured":"Kohler, L. J. et al. Effector protein Cig2 decreases host tolerance of infection by directing constitutive fusion of autophagosomes with the coxiella-containing vacuole. mBio 7, e01127-16 (2016).","journal-title":"mBio"},{"key":"727_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fcimb.2017.00112","volume":"7","author":"ME Mansilla Pareja","year":"2017","unstructured":"Mansilla Pareja, M. E. et al. Alterations of the Coxiella burnetii replicative vacuole membrane integrity and interplay with the autophagy pathway. Front. Cell Infect. Microbiol. 7, 112 (2017).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"727_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1034\/j.1600-0854.2002.030302.x","volume":"3","author":"MS Swanson","year":"2002","unstructured":"Swanson, M. S. & Fernandez\u2010Moreia, E. A microbial strategy to multiply in macrophages: the pregnant pause. Traffic 3, 170\u2013177 (2002).","journal-title":"Traffic"},{"key":"727_CR46","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1128\/IAI.70.9.5140-5147.2002","volume":"70","author":"D Howe","year":"2002","unstructured":"Howe, D. et al. Nitric oxide inhibits Coxiella burnetii replication and parasitophorous vacuole maturation. Infect. Immun. 70, 5140\u20135147 (2002).","journal-title":"Infect. Immun."},{"key":"727_CR47","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1128\/IAI.00594-07","volume":"75","author":"DE Voth","year":"2007","unstructured":"Voth, D. E., Howe, D. & Heinzen, R. A. Coxiella burnetii inhibits apoptosis in human THP-1 cells and monkey primary alveolar macrophages. Infect. Immun. 75, 4263\u20134271 (2007).","journal-title":"Infect. Immun."},{"key":"727_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1128\/IAI.01124-08","volume":"77","author":"DE Voth","year":"2009","unstructured":"Voth, D. E. & Heinzen, R. A. Sustained activation of Akt and Erk1\/2 is required for Coxiella burnetii antiapoptotic activity. Infect. Immun. 77, 205\u2013213 (2009).","journal-title":"Infect. Immun."},{"key":"727_CR49","doi-asserted-by":"publisher","first-page":"e30841","DOI":"10.1371\/journal.pone.0030841","volume":"7","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Coxiella burnetii induces apoptosis during early stage infection via a caspase-independent pathway in human monocytic THP-1 cells. PLoS ONE 7, e30841 (2012).","journal-title":"PLoS ONE"},{"key":"727_CR50","doi-asserted-by":"publisher","first-page":"e03545-22","DOI":"10.1128\/mbio.03545-22","volume":"14","author":"S Ganesan","year":"2023","unstructured":"Ganesan, S. et al. Syntaxin 11 contributes to the interferon-inducible restriction of Coxiella burnetii intracellular infection. Mbio 14, e03545-22 (2023).","journal-title":"Mbio"},{"key":"727_CR51","doi-asserted-by":"crossref","unstructured":"Peters, N. C., Khan, N. & Mody, C. H. Novel approaches to preventing phagosomal infections: timing is key. Trends Immunol. 44, 22\u201331 (2022).","DOI":"10.1016\/j.it.2022.11.004"},{"key":"727_CR52","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.pt.2022.08.007","volume":"38","author":"B Rayamajhee","year":"2022","unstructured":"Rayamajhee, B. et al. Acanthamoeba, an environmental phagocyte enhancing survival and transmission of human pathogens. Trends Parasitol. 38, 975\u2013990 (2022).","journal-title":"Trends Parasitol."},{"key":"727_CR53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.15212\/ZOONOSES-2021-0011","volume":"1","author":"JR Fisher","year":"2021","unstructured":"Fisher, J. R. et al. Pattern recognition receptors in innate immunity to obligate intracellular bacteria. Zoonoses 1, 10 (2021).","journal-title":"Zoonoses"},{"key":"727_CR54","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.4049\/jimmunol.181.6.3733","volume":"181","author":"M Benoit","year":"2008","unstructured":"Benoit, M., Desnues, B. & Mege, J. L. Macrophage polarization in bacterial infections. J. Immunol. 181, 3733\u20133739 (2008).","journal-title":"J. Immunol."},{"key":"727_CR55","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3389\/fimmu.2014.00500","volume":"5","author":"MB Ka","year":"2014","unstructured":"Ka, M. B. et al. Phenotypic diversity and emerging new tools to study macrophage activation in bacterial infectious diseases. Front. Immunol. 5, 500 (2014).","journal-title":"Front. Immunol."},{"key":"727_CR56","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fimmu.2014.00532","volume":"5","author":"M Rath","year":"2014","unstructured":"Rath, M. et al. Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages. Front. Immunol. 5, 532 (2014).","journal-title":"Front. Immunol."},{"key":"727_CR57","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nri957","volume":"2","author":"J Savill","year":"2002","unstructured":"Savill, J. et al. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2, 965\u2013975 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"727_CR58","doi-asserted-by":"publisher","first-page":"e1000066","DOI":"10.1371\/journal.ppat.1000066","volume":"4","author":"M Benoit","year":"2008","unstructured":"Benoit, M. et al. The uptake of apoptotic cells drives Coxiella burnetii replication and macrophage polarization: a model for Q fever endocarditis. PLoS Pathog. 4, e1000066 (2008).","journal-title":"PLoS Pathog."},{"key":"727_CR59","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1128\/iai.19.1.194-198.1978","volume":"19","author":"R Kishimoto","year":"1978","unstructured":"Kishimoto, R. et al. Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine. Infect. Immun. 19, 194\u2013198 (1978).","journal-title":"Infect. Immun."},{"key":"727_CR60","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3389\/fimmu.2020.01276","volume":"11","author":"EM Muntjewerff","year":"2020","unstructured":"Muntjewerff, E. M., Meesters, L. D. & van den Bogaart, G. Antigen cross-presentation by macrophages. Front. Immunol. 11, 1276 (2020).","journal-title":"Front. Immunol."},{"key":"727_CR61","doi-asserted-by":"publisher","first-page":"e00602-17","DOI":"10.1128\/IAI.00602-17","volume":"86","author":"L Buttrum","year":"2018","unstructured":"Buttrum, L. et al. Both major histocompatibility complex class I (MHC-I) and MHC-II molecules are required, while MHC-I appears to play a critical role in host defense against primary Coxiella burnetii infection. Infect. Immun. 86, e00602-17 (2018).","journal-title":"Infect. Immun."},{"key":"727_CR62","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1196\/annals.1355.025","volume":"1063","author":"S Meghari","year":"2005","unstructured":"Meghari, S. et al. TLR2 is necessary to inflammatory response in Coxiella burnetii infection. Ann. N. Y. Acad. Sci. 1063, 161\u2013166 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"727_CR63","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","volume":"5","author":"G Arango Duque","year":"2014","unstructured":"Arango Duque, G. & Descoteaux, A. Macrophage cytokines: involvement in immunity and infectious diseases. Front. Immunol. 5, 491 (2014).","journal-title":"Front. Immunol."},{"key":"727_CR64","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/IAI.00973-13","volume":"81","author":"A Elliott","year":"2013","unstructured":"Elliott, A., Peng, Y. & Zhang, G. Coxiella burnetii interaction with neutrophils and macrophages in vitro and in SCID mice following aerosol infection. Infect. Immun. 81, 4604\u20134614 (2013).","journal-title":"Infect. Immun."},{"key":"727_CR65","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1128\/IAI.00042-15","volume":"83","author":"A Elliott","year":"2015","unstructured":"Elliott, A. et al. Neutrophils play an important role in protective immunity against Coxiella burnetii infection. Infect. Immun. 83, 3104\u20133113 (2015).","journal-title":"Infect. Immun."},{"key":"727_CR66","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/infdis\/jiz146","volume":"220","author":"C Chen","year":"2019","unstructured":"Chen, C. et al. Chemokine receptor 7 is essential for Coxiella burnetii whole-cell vaccine-induced cellular immunity but dispensable for vaccine-mediated protective immunity. J. Infect. Dis. 220, 624\u2013634 (2019).","journal-title":"J. Infect. Dis."},{"key":"727_CR67","doi-asserted-by":"publisher","first-page":"8722","DOI":"10.1073\/pnas.0501863102","volume":"102","author":"JG Shannon","year":"2005","unstructured":"Shannon, J. G., Howe, D. & Heinzen, R. A. Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule. Proc. Natl Acad. Sci. 102, 8722\u20138727 (2005).","journal-title":"Proc. Natl Acad. Sci."},{"key":"727_CR68","doi-asserted-by":"publisher","first-page":"e99420","DOI":"10.1371\/journal.pone.0099420","volume":"9","author":"L Gorvel","year":"2014","unstructured":"Gorvel, L. et al. Intracellular bacteria interfere with dendritic cell functions: role of the type I interferon pathway. PLoS ONE 9, e99420 (2014).","journal-title":"PLoS ONE"},{"key":"727_CR69","doi-asserted-by":"publisher","first-page":"e00323-22","DOI":"10.1128\/iai.00323-22","volume":"91","author":"S Matthiesen","year":"2023","unstructured":"Matthiesen, S. et al. TGF-\u03b2\/IFN-\u03b3 antagonism in subversion and self-defense of phase II Coxiella burnetii-infected dendritic cells. Infect. Immun. 91, e00323-22 (2023).","journal-title":"Infect. Immun."},{"key":"727_CR70","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00262-008-0489-2","volume":"57","author":"AC Boullart","year":"2008","unstructured":"Boullart, A. C. et al. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7\/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration. Cancer Immunol. Immunother. 57, 1589\u20131597 (2008).","journal-title":"Cancer Immunol. Immunother."},{"key":"727_CR71","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/imr.12758","volume":"289","author":"B Leon","year":"2019","unstructured":"Leon, B. & Lund, F. E. Compartmentalization of dendritic cell and T-cell interactions in the lymph node: anatomy of T-cell fate decisions. Immunol. Rev. 289, 84\u2013100 (2019).","journal-title":"Immunol. Rev."},{"key":"727_CR72","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/infdis\/jiq037","volume":"203","author":"Y Wei","year":"2011","unstructured":"Wei, Y. et al. Coxiella burnetii antigen-stimulated dendritic cells mediated protection against Coxiella burnetii in BALB\/c mice. J. Infect. Dis. 203, 283\u2013291 (2011).","journal-title":"J. Infect. Dis."},{"key":"727_CR73","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nri3536","volume":"13","author":"V Lazarevic","year":"2013","unstructured":"Lazarevic, V., Glimcher, L. H. & Lord, G. M. T-bet: a bridge between innate and adaptive immunity. Nat. Rev. Immunol. 13, 777\u2013789 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"727_CR74","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3389\/fmicb.2020.01546","volume":"11","author":"S Mezouar","year":"2020","unstructured":"Mezouar, S. et al. T-Bet controls susceptibility of mice to Coxiella burnetii infection. Front. Microbiol 11, 1546 (2020).","journal-title":"Front. Microbiol"},{"key":"727_CR75","doi-asserted-by":"publisher","first-page":"e00824-19","DOI":"10.1128\/IAI.00824-19","volume":"88","author":"L Ledbetter","year":"2020","unstructured":"Ledbetter, L. et al. Major histocompatibility complex class II-Restricted, CD4+ T cell-dependent and-independent mechanisms are required for vaccine-induced protective immunity against Coxiella burnetii. Infect. Immun. 88, e00824-19 (2020).","journal-title":"Infect. Immun."},{"key":"727_CR76","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1128\/IAI.01767-06","volume":"75","author":"M Andoh","year":"2007","unstructured":"Andoh, M. et al. T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice. Infect. Immun. 75, 3245\u20133255 (2007).","journal-title":"Infect. Immun."},{"key":"727_CR77","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1128\/IAI.00101-10","volume":"78","author":"AJ Read","year":"2010","unstructured":"Read, A. J., Erickson, S. & Harmsen, A. G. Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii. Infect. Immun. 78, 3019\u20133026 (2010).","journal-title":"Infect. Immun."},{"key":"727_CR78","doi-asserted-by":"publisher","first-page":"8372","DOI":"10.4049\/jimmunol.179.12.8372","volume":"179","author":"G Zhang","year":"2007","unstructured":"Zhang, G. et al. Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB\/c mice. J. Immunol. 179, 8372\u20138380 (2007).","journal-title":"J. Immunol."},{"key":"727_CR79","doi-asserted-by":"crossref","unstructured":"Nash, A. A., Dalziel, R. G. & Fitzgerald, J. R. Early stages of infection after pathogen entry. In Mims\u2019 Pathogenesis of Infectious Disease (ed. Fitzgerald, J. R.) 51\u201365 (Academic Press, 2015).","DOI":"10.1016\/B978-0-12-397188-3.00003-2"},{"key":"727_CR80","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1365-2249.1991.tb05689.x","volume":"85","author":"A Izzo","year":"1991","unstructured":"Izzo, A., Marmion, B. & Hackstadt, T. Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens. Clin. Exp. Immunol. 85, 98\u2013108 (1991).","journal-title":"Clin. Exp. Immunol."},{"key":"727_CR81","doi-asserted-by":"publisher","first-page":"901372","DOI":"10.3389\/fimmu.2022.901372","volume":"13","author":"AE Sluder","year":"2022","unstructured":"Sluder, A. E. et al. Evaluation of a human T cell-targeted multi-epitope vaccine for Q fever in animal models of Coxiella burnetii immunity. Front. Immunol. 13, 901372 (2022).","journal-title":"Front. Immunol."},{"key":"727_CR82","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3389\/fmicb.2019.02022","volume":"10","author":"J Dresler","year":"2019","unstructured":"Dresler, J. et al. Quantitative proteome profiling of Coxiella burnetii reveals major metabolic and stress differences under axenic and cell culture cultivation. Front. Microbiol. 10, 2022 (2019).","journal-title":"Front. Microbiol."},{"key":"727_CR83","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.1128\/IAI.72.11.6666-6675.2004","volume":"72","author":"RE Brennan","year":"2004","unstructured":"Brennan, R. E. et al. Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections. Infect. Immun. 72, 6666\u20136675 (2004).","journal-title":"Infect. Immun."},{"key":"727_CR84","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S1471-4906(03)00228-X","volume":"24","author":"A Casadevall","year":"2003","unstructured":"Casadevall, A. & Pirofski, L.-A. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol. 24, 474\u2013478 (2003).","journal-title":"Trends Immunol."},{"key":"727_CR85","doi-asserted-by":"crossref","unstructured":"Casadevall, A. & Pirofski, L. A. A reappraisal of humoral immunity based on mechanisms of antibody\u2010mediated protection against intracellular pathogens. Adv. Immunol. 91, 1\u201344 (2006).","DOI":"10.1016\/S0065-2776(06)91001-3"},{"key":"727_CR86","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1128\/IAI.00297-13","volume":"81","author":"G Zhang","year":"2013","unstructured":"Zhang, G. et al. Formalin-inactivated Coxiella burnetii phase I vaccine-induced protection depends on B cells to produce protective IgM and IgG. Infect. Immun. 81, 2112\u20132122 (2013).","journal-title":"Infect. Immun."},{"key":"727_CR87","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2172-10-26","volume":"10","author":"JG Shannon","year":"2009","unstructured":"Shannon, J. G. et al. Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent. BMC Immunol. 10, 26 (2009).","journal-title":"BMC Immunol."},{"key":"727_CR88","doi-asserted-by":"publisher","first-page":"996","DOI":"10.4049\/jimmunol.117.3.996","volume":"117","author":"DJ Hinrichs","year":"1976","unstructured":"Hinrichs, D. J. & Jerrells, T. R. In vitro evaluation of immunity to Coxiella burnetii. J. Immunol. 117, 996\u20131003 (1976).","journal-title":"J. Immunol."},{"key":"727_CR89","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1128\/IAI.01073-15","volume":"83","author":"L Schoenlaub","year":"2015","unstructured":"Schoenlaub, L. et al. Role of B cells in host defense against primary Coxiella burnetii infection. Infect. Immun. 83, 4826\u20134836 (2015).","journal-title":"Infect. Immun."},{"key":"727_CR90","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1128\/am.27.4.777-783.1974","volume":"27","author":"DM Robinson","year":"1974","unstructured":"Robinson, D. M. & Hasty, S. E. Production of a potent vaccine from the attenuated M-44 strain of Coxiella burneti. Appl. Microbiol. 27, 777\u2013783 (1974).","journal-title":"Appl. Microbiol."},{"key":"727_CR91","unstructured":"Genig, V. et al. Experience on the mass immunization of humans with the M-44 live vaccine against Q-fever. I. Subcutaneous method of immunization. Vopr. Virusol. 3, 319\u2013323 (1966)."},{"key":"727_CR92","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/infdis\/135.6.995","volume":"135","author":"JW Johnson","year":"1977","unstructured":"Johnson, J. W. et al. Lesions in guinea pigs infected with Coxiella burnetii strain M-44. J. Infect. Dis. 135, 995\u2013998 (1977).","journal-title":"J. Infect. Dis."},{"key":"727_CR93","doi-asserted-by":"publisher","first-page":"754690","DOI":"10.3389\/fimmu.2021.754690","volume":"12","author":"V Kumaresan","year":"2021","unstructured":"Kumaresan, V. et al. The feasibility of using Coxiella burnetii avirulent nine mile phase II viable bacteria as a live attenuated vaccine against Q fever. Front. Immunol. 12, 754690 (2021).","journal-title":"Front. Immunol."},{"key":"727_CR94","first-page":"71","volume":"47","author":"JE Smadel","year":"1948","unstructured":"Smadel, J. E., Snyder, M. J. & Robbins, F. C. Vaccination against Q fever. Am. J. Hyg. 47, 71\u201381 (1948).","journal-title":"Am. J. Hyg."},{"key":"727_CR95","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1017\/S0950268800059458","volume":"104","author":"B Marmion","year":"1990","unstructured":"Marmion, B. et al. Vaccine prophylaxis of abattoir-associated Q fever: eight years\u2019 experience in Australian abattoirs. Epidemiol. Infect. 104, 275\u2013287 (1990).","journal-title":"Epidemiol. Infect."},{"key":"727_CR96","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0140-6736(84)91617-9","volume":"324","author":"B Marmion","year":"1984","unstructured":"Marmion, B. et al. Vaccine prophylaxis of abattoir-associated Q fever. Lancet 324, 1411\u20131414 (1984).","journal-title":"Lancet"},{"key":"727_CR97","doi-asserted-by":"publisher","first-page":"704","DOI":"10.5694\/j.1326-5377.1994.tb125909.x","volume":"160","author":"JR Ackland","year":"1994","unstructured":"Ackland, J. R., Worswick, D. A. & Marmion, B. P. Vaccine prophylaxis of Q fever: a follow\u2010up study of the efficacy of Q\u2010Vax (CSL) 1985\u20101990. Med. J. Aust. 160, 704\u2013708 (1994).","journal-title":"Med. J. Aust."},{"key":"727_CR98","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/vaccines6040083","volume":"6","author":"E Sellens","year":"2018","unstructured":"Sellens, E. et al. Frequency of adverse events following Q fever immunisation in young adults. Vaccines 6, 83 (2018).","journal-title":"Vaccines"},{"key":"727_CR99","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/milmed\/129.7.591","volume":"129","author":"JF Bell","year":"1964","unstructured":"Bell, J. F. et al. Recurrent reaction at site of Q fever vaccination in a sensitized person. Mil. Med. 129, 591\u2013595 (1964).","journal-title":"Mil. Med."},{"key":"727_CR100","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1016\/j.vaccine.2014.09.061","volume":"32","author":"T Schoffelen","year":"2014","unstructured":"Schoffelen, T. et al. Adverse events and association with age, sex and immunological parameters of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011. Vaccine 32, 6622\u20136630 (2014).","journal-title":"Vaccine"},{"key":"727_CR101","doi-asserted-by":"publisher","first-page":"754712","DOI":"10.3389\/fimmu.2021.754712","volume":"12","author":"AP Fratzke","year":"2021","unstructured":"Fratzke, A. P. et al. Coxiella burnetii whole cell vaccine produces a Th1 delayed-type hypersensitivity response in a novel sensitized mouse model. Front. Immunol. 12, 754712 (2021).","journal-title":"Front. Immunol."},{"key":"727_CR102","first-page":"389","volume":"60","author":"J Kazar","year":"1982","unstructured":"Kazar, J. et al. Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia. Bull. World Health Organ. 60, 389 (1982).","journal-title":"Bull. World Health Organ."},{"key":"727_CR103","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1749-6632.1992.tb19633.x","volume":"653","author":"JC Williams","year":"1992","unstructured":"Williams, J. C. et al. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals. Ann. N. Y. Acad. Sci. 653, 88\u2013111 (1992).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"727_CR104","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/S0264-410X(02)00176-7","volume":"20","author":"DM Waag","year":"2002","unstructured":"Waag, D. M. et al. Comparative efficacy and immunogenicity of Q fever chloroform: methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol. Vaccine 20, 2623\u20132634 (2002).","journal-title":"Vaccine"},{"key":"727_CR105","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0264-410X(97)00107-2","volume":"15","author":"DM Waag","year":"1997","unstructured":"Waag, D. M., England, M. J. & Pitt, M. L. M. Comparative efficacy of a Coxiella burnetii chloroform: methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol. Vaccine 15, 1779\u20131783 (1997).","journal-title":"Vaccine"},{"key":"727_CR106","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1128\/iai.61.4.1251-1258.1993","volume":"61","author":"L Fries","year":"1993","unstructured":"Fries, L., Waag, D. & Williams, J. Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever. Infect. Immun. 61, 1251\u20131258 (1993).","journal-title":"Infect. Immun."},{"key":"727_CR107","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1128\/jb.85.5.1165-1170.1963","volume":"85","author":"R Anacker","year":"1963","unstructured":"Anacker, R. et al. Conversion of the phase I antigen of Coxiella burnetii to hapten by phenol treatment. J. Bacteriol. 85, 1165\u20131170 (1963).","journal-title":"J. Bacteriol."},{"key":"727_CR108","doi-asserted-by":"publisher","first-page":"100461","DOI":"10.1016\/j.xcrm.2021.100461","volume":"2","author":"AE Gregory","year":"2021","unstructured":"Gregory, A. E. et al. Soluble antigens derived from Coxiella burnetii elicit protective immunity in three animal models without inducing hypersensitivity. Cell Rep. Med. 2, 100461 (2021).","journal-title":"Cell Rep. Med."},{"key":"727_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0132-6","volume":"4","author":"C Herve","year":"2019","unstructured":"Herve, C. et al. The how\u2019s and what\u2019s of vaccine reactogenicity. npj Vaccines 4, 39 (2019).","journal-title":"npj Vaccines"},{"key":"727_CR110","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jaci.2017.12.971","volume":"141","author":"MM McNeil","year":"2018","unstructured":"McNeil, M. M. & DeStefano, F. Vaccine-associated hypersensitivity. J. Allergy Clin. Immunol. 141, 463\u2013472 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"727_CR111","doi-asserted-by":"publisher","first-page":"886810","DOI":"10.3389\/fimmu.2022.886810","volume":"13","author":"AP Fratzke","year":"2022","unstructured":"Fratzke, A. P., van Schaik, E. J. & Samuel, J. E. Immunogenicity and reactogenicity in Q fever vaccine development. Front. Immunol. 13, 886810 (2022).","journal-title":"Front. Immunol."},{"key":"727_CR112","doi-asserted-by":"publisher","first-page":"927306","DOI":"10.3389\/fmicb.2022.927306","volume":"13","author":"M Heidary","year":"2022","unstructured":"Heidary, M. et al. A comprehensive review of the protein subunit vaccines against COVID-19. Front. Microbiol. 13, 927306 (2022).","journal-title":"Front. Microbiol."},{"key":"727_CR113","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/cmdc.201200487","volume":"8","author":"PM Moyle","year":"2013","unstructured":"Moyle, P. M. & Toth, I. Modern subunit vaccines: development, components, and research opportunities. ChemMedChem 8, 360\u2013376 (2013).","journal-title":"ChemMedChem"},{"key":"727_CR114","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/vaccines4020012","volume":"4","author":"A Vartak","year":"2016","unstructured":"Vartak, A. & Sucheck, S. J. Recent advances in subunit vaccine carriers. Vaccines 4, 12 (2016).","journal-title":"Vaccines"},{"key":"727_CR115","doi-asserted-by":"publisher","first-page":"1131057","DOI":"10.3389\/fimmu.2023.1131057","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. Precision-engineering of subunit vaccine particles for prevention of infectious diseases. Front. Immunol. 14, 1131057 (2023).","journal-title":"Front. Immunol."},{"key":"727_CR116","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4049\/jimmunol.1900991","volume":"204","author":"AP Gilkes","year":"2020","unstructured":"Gilkes, A. P. et al. Tuning subunit vaccines with novel TLR triagonist adjuvants to generate protective immune responses against Coxiella burnetii. J. Immunol. 204, 611\u2013621 (2020).","journal-title":"J. Immunol."},{"key":"727_CR117","doi-asserted-by":"publisher","first-page":"653092","DOI":"10.3389\/fimmu.2021.653092","volume":"12","author":"AP Fratzke","year":"2021","unstructured":"Fratzke, A. P. et al. Subunit vaccines using TLR triagonist combination adjuvants provide protection against Coxiella burnetii while minimizing reactogenic responses. Front. Immunol. 12, 653092 (2021).","journal-title":"Front. Immunol."},{"key":"727_CR118","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.4049\/jimmunol.1201622","volume":"189","author":"Y Peng","year":"2012","unstructured":"Peng, Y. et al. Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever. J. Immunol. 189, 4909\u20134920 (2012).","journal-title":"J. Immunol."},{"key":"727_CR119","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ijbiomac.2022.12.158","volume":"227","author":"Y Feng","year":"2023","unstructured":"Feng, Y. et al. DEC-205 receptor targeted poly(lactic-co-glycolic acid) nanoparticles containing Eucommia ulmoides polysaccharide enhances the immune response of foot-and-mouth disease vaccine in mice. Int. J. Biol. Macromol. 227, 576\u2013589 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"727_CR120","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4049\/jimmunol.175.1.196","volume":"175","author":"GT Belz","year":"2005","unstructured":"Belz, G. T. et al. CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 175, 196\u2013200 (2005).","journal-title":"J. Immunol."},{"key":"727_CR121","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1182\/blood-2011-08-373944","volume":"119","author":"G Schreibelt","year":"2012","unstructured":"Schreibelt, G. et al. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells. Blood 119, 2284\u20132292 (2012).","journal-title":"Blood"},{"key":"727_CR122","doi-asserted-by":"publisher","first-page":"786144","DOI":"10.3389\/fimmu.2021.786144","volume":"12","author":"V Ceglia","year":"2021","unstructured":"Ceglia, V. et al. Anti-CD40 antibody fused to CD40 ligand is a superagonist platform for adjuvant intrinsic DC-targeting vaccines. Front. Immunol. 12, 786144 (2021).","journal-title":"Front. Immunol."},{"key":"727_CR123","doi-asserted-by":"publisher","first-page":"745016","DOI":"10.3389\/fcimb.2021.745016","volume":"11","author":"GH Ong","year":"2021","unstructured":"Ong, G. H. et al. Exploration of pattern recognition receptor agonists as candidate adjuvants. Front. Cell Infect. Microbiol. 11, 745016 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"727_CR124","doi-asserted-by":"publisher","first-page":"102172","DOI":"10.1016\/j.cbpa.2022.102172","volume":"70","author":"A Kaur","year":"2022","unstructured":"Kaur, A. et al. Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics. Curr. Opin. Chem. Biol. 70, 102172 (2022).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"727_CR125","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s11094-020-02111-3","volume":"53","author":"NA Alpatova","year":"2020","unstructured":"Alpatova, N. A. et al. Adjuvant properties of cytokines in vaccination (Review). Pharm. Chem. J. 53, 991\u2013996 (2020).","journal-title":"Pharm. Chem. J."},{"key":"727_CR126","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.2147\/IJN.S317113","volume":"16","author":"H Zhao","year":"2021","unstructured":"Zhao, H. et al. Chitosan nanovaccines as efficient carrier adjuvant system for IL-12 with enhanced protection against HBV. Int. J. Nanomed. 16, 4913\u20134928 (2021).","journal-title":"Int. J. Nanomed."},{"key":"727_CR127","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cell.2019.11.032","volume":"180","author":"L Mesin","year":"2020","unstructured":"Mesin, L. et al. Restricted clonality and limited germinal center reentry characterize memory B cell reactivation by boosting. Cell 180, 92\u2013106.e11 (2020).","journal-title":"Cell"},{"key":"727_CR128","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-021-00657-1","volume":"22","author":"BJ Laidlaw","year":"2022","unstructured":"Laidlaw, B. J. & Ellebedy, A. H. The germinal centre B cell response to SARS-CoV-2. Nat. Rev. Immunol. 22, 7\u201318 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"727_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29978-y","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Recycling of memory B cells between germinal center and lymph node subcapsular sinus supports affinity maturation to antigenic drift. Nat. Commun. 13, 2460 (2022).","journal-title":"Nat. Commun."},{"key":"727_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05772-7","volume":"9","author":"I Moran","year":"2018","unstructured":"Moran, I. et al. Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes. Nat. Commun. 9, 3372 (2018).","journal-title":"Nat. Commun."},{"key":"727_CR131","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/ni1139","volume":"5","author":"RL Lindquist","year":"2004","unstructured":"Lindquist, R. L. et al. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5, 1243\u201350 (2004).","journal-title":"Nat. Immunol."},{"key":"727_CR132","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.immuni.2007.06.007","volume":"27","author":"YR Carrasco","year":"2007","unstructured":"Carrasco, Y. R. & Batista, F. D. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity 27, 160\u2013171 (2007).","journal-title":"Immunity"},{"key":"727_CR133","doi-asserted-by":"publisher","first-page":"110901","DOI":"10.1016\/j.celrep.2022.110901","volume":"39","author":"DM Hinke","year":"2022","unstructured":"Hinke, D. M. et al. Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses. Cell Rep. 39, 110901 (2022).","journal-title":"Cell Rep."},{"key":"727_CR134","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.immuni.2020.08.001","volume":"53","author":"Y Kato","year":"2020","unstructured":"Kato, Y. et al. Multifaceted effects of antigen valency on B cell response composition and differentiation in vivo. Immunity 53, 548\u2013563.e8 (2020).","journal-title":"Immunity"},{"key":"727_CR135","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.15252\/embj.201694177","volume":"35","author":"C Volkmann","year":"2016","unstructured":"Volkmann, C. et al. Molecular requirements of the B-cell antigen receptor for sensing monovalent antigens. EMBO J. 35, 2371\u20132381 (2016).","journal-title":"EMBO J."},{"key":"727_CR136","doi-asserted-by":"publisher","first-page":"e2102089","DOI":"10.1002\/adhm.202102089","volume":"11","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Ambient temperature stable, scalable COVID-19 polymer particle vaccines induce protective immunity. Adv. Health. Mater. 11, e2102089 (2022).","journal-title":"Adv. Health. Mater."},{"key":"727_CR137","doi-asserted-by":"crossref","unstructured":"Chen, S. et al. Assembly of immunogenic protein particles toward advanced synthetic vaccines. Small 19, e2205819 (2022).","DOI":"10.1002\/smll.202205819"},{"key":"727_CR138","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1080\/08820139.2021.1903033","volume":"50","author":"W Luo","year":"2021","unstructured":"Luo, W. & Yin, Q. B cell response to vaccination. Immunol. Invest. 50, 780\u2013801 (2021).","journal-title":"Immunol. Invest."},{"key":"727_CR139","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1126\/science.aat9120","volume":"363","author":"T Tokatlian","year":"2019","unstructured":"Tokatlian, T. et al. Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers. Science 363, 649\u2013654 (2019).","journal-title":"Science"},{"key":"727_CR140","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41565-020-00790-3","volume":"16","author":"A Singh","year":"2021","unstructured":"Singh, A. Eliciting B cell immunity against infectious diseases using nanovaccines. Nat. Nanotechnol. 16, 16\u201324 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"727_CR141","doi-asserted-by":"publisher","first-page":"101702","DOI":"10.1016\/j.smim.2022.101702","volume":"65","author":"S This","year":"2023","unstructured":"This, S. et al. What\u2019s self got to do with it: sources of heterogeneity among naive T cells. Semin. Immunol. 65, 101702 (2023).","journal-title":"Semin. Immunol."},{"key":"727_CR142","doi-asserted-by":"publisher","first-page":"e2250305","DOI":"10.1002\/eji.202250305","volume":"53","author":"K van Gisbergen","year":"2023","unstructured":"van Gisbergen, K. & Gerlach, C. No-shows in T-cell responses are frequent for clones of low T-cell receptor affinity. Eur. J. Immunol. 53, e2250305 (2023).","journal-title":"Eur. J. Immunol."},{"key":"727_CR143","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nri778","volume":"2","author":"SM Kaech","year":"2002","unstructured":"Kaech, S. M., Wherry, E. J. & Ahmed, R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2, 251\u2013262 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"727_CR144","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1021\/acsbiomaterials.8b00579","volume":"4","author":"M Gonz\u00e1lez-Mir\u00f3","year":"2018","unstructured":"Gonz\u00e1lez-Mir\u00f3, M. et al. Design and biological assembly of polyester beads displaying pneumococcal antigens as particulate vaccine. ACS Biomater. Sci. Eng. 4, 3413\u20133424 (2018).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"727_CR145","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1021\/acsinfecdis.1c00434","volume":"8","author":"ZJC Gonzaga","year":"2022","unstructured":"Gonzaga, Z. J. C., Zhang, J. & Rehm, B. H. Intranasal delivery of antigen-coated polymer particles protects against Pseudomonas aeruginosa infection. ACS Infect. Dis. 8, 744\u2013756 (2022).","journal-title":"ACS Infect. Dis."},{"key":"727_CR146","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jconrel.2022.09.044","volume":"351","author":"Z Teng","year":"2022","unstructured":"Teng, Z. et al. Bridging nanoplatform and vaccine delivery, a landscape of strategy to enhance nasal immunity. J. Control Release 351, 456\u2013475 (2022).","journal-title":"J. Control Release"},{"key":"727_CR147","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1080\/21645515.2015.1114195","volume":"12","author":"F Su","year":"2016","unstructured":"Su, F. et al. Induction of mucosal immunity through systemic immunization: phantom or reality? Hum. Vaccin. Immunother. 12, 1070\u20131079 (2016).","journal-title":"Hum. Vaccin. Immunother."},{"key":"727_CR148","doi-asserted-by":"publisher","first-page":"M110.006304","DOI":"10.1074\/mcp.M110.006304","volume":"10","author":"A Vigil","year":"2011","unstructured":"Vigil, A. et al. Profiling the humoral immune response of acute and chronic Q fever by protein microarray. Mol. Cell Proteom. 10, M110.006304 (2011).","journal-title":"Mol. Cell Proteom."},{"key":"727_CR149","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1099\/mic.0.082131-0","volume":"160","author":"J Jiao","year":"2014","unstructured":"Jiao, J. et al. Serological characterization of surface-exposed proteins of Coxiella burnetii. Microbiology 160, 2718\u20132731 (2014).","journal-title":"Microbiology"},{"key":"727_CR150","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1128\/CVI.00300-08","volume":"15","author":"PA Beare","year":"2008","unstructured":"Beare, P. A. et al. Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray. Clin. Vaccin. Immunol. 15, 1771\u20131779 (2008).","journal-title":"Clin. Vaccin. Immunol."},{"key":"727_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-12-35","volume":"12","author":"X Xiong","year":"2012","unstructured":"Xiong, X. et al. Potential serodiagnostic markers for Q fever identified in Coxiella burnetii by immunoproteomic and protein microarray approaches. BMC Microbiol. 12, 35 (2012).","journal-title":"BMC Microbiol."},{"key":"727_CR152","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1002\/pmic.201000064","volume":"10","author":"A Vigil","year":"2010","unstructured":"Vigil, A. et al. Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray. Proteomics 10, 2259\u20132269 (2010).","journal-title":"Proteomics"},{"key":"727_CR153","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fimmu.2019.00207","volume":"10","author":"A Scholzen","year":"2019","unstructured":"Scholzen, A. et al. Promiscuous Coxiella burnetii CD4 epitope clusters associated with human recall responses are candidates for a novel T-cell targeted multi-epitope Q fever vaccine. Front. Immunol. 10, 207 (2019).","journal-title":"Front. Immunol."},{"key":"727_CR154","doi-asserted-by":"publisher","first-page":"e00213-19","DOI":"10.1128\/IAI.00213-19","volume":"87","author":"A Scholzen","year":"2019","unstructured":"Scholzen, A. et al. Coxiella burnetii epitope-specific T-cell responses in patients with chronic Q fever. Infect. Immun. 87, e00213-19 (2019).","journal-title":"Infect. Immun."},{"key":"727_CR155","doi-asserted-by":"publisher","first-page":"e87206","DOI":"10.1371\/journal.pone.0087206","volume":"9","author":"X Xiong","year":"2014","unstructured":"Xiong, X. et al. Exploratory study on Th1 epitope-induced protective immunity against Coxiella burnetii infection. PLoS ONE 9, e87206 (2014).","journal-title":"PLoS ONE"},{"key":"727_CR156","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1016\/j.vaccine.2023.04.012","volume":"41","author":"C Dold","year":"2023","unstructured":"Dold, C. et al. Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines. Vaccine 41, 3047\u20133057 (2023).","journal-title":"Vaccine"},{"key":"727_CR157","first-page":"1580","volume":"215","author":"X Xiong","year":"2017","unstructured":"Xiong, X. et al. Identification of Coxiella burnetii CD8+ T-cell epitopes and delivery by attenuated listeria monocytogenes as a vaccine vector in a C57BL\/6 mouse model. J. Infect. Dis. 215, 1580\u20131589 (2017).","journal-title":"J. Infect. Dis."},{"key":"727_CR158","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri2868","volume":"10","author":"MF Bachmann","year":"2010","unstructured":"Bachmann, M. F. & Jennings, G. T. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10, 787\u2013796 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"727_CR159","doi-asserted-by":"publisher","first-page":"120597","DOI":"10.1016\/j.biomaterials.2020.120597","volume":"268","author":"D Wibowo","year":"2021","unstructured":"Wibowo, D. et al. Polymeric nanoparticle vaccines to combat emerging and pandemic threats. Biomaterials 268, 120597 (2021).","journal-title":"Biomaterials"},{"key":"727_CR160","doi-asserted-by":"publisher","first-page":"607945","DOI":"10.3389\/fimmu.2020.607945","volume":"11","author":"MV Baranov","year":"2020","unstructured":"Baranov, M. V. et al. Modulation of immune responses by particle size and shape. Front. Immunol. 11, 607945 (2020).","journal-title":"Front. Immunol."},{"key":"727_CR161","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3390\/nano11082060","volume":"11","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Particulate mycobacterial vaccines induce protective immunity against tuberculosis in mice. Nanomaterials 11, 2060 (2021).","journal-title":"Nanomaterials"},{"key":"727_CR162","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1096\/fj.201802501RR","volume":"33","author":"S Chen","year":"2019","unstructured":"Chen, S. et al. Innovative antigen carrier system for the development of tuberculosis vaccines. FASEB J. 33, 7505\u20137518 (2019).","journal-title":"FASEB J."},{"key":"727_CR163","doi-asserted-by":"publisher","first-page":"828784","DOI":"10.3389\/fcimb.2022.828784","volume":"12","author":"M Tesfamariam","year":"2022","unstructured":"Tesfamariam, M., Binette, P. & Long, C. M. Preclinical animal models for Q fever vaccine development. Front. Cell Infect. Microbiol. 12, 828784 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"727_CR164","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1099\/mic.0.077230-0","volume":"160","author":"IH Norville","year":"2014","unstructured":"Norville, I. H. et al. Galleria mellonella as an alternative model of Coxiella burnetii infection. Microbiology 160, 1175\u20131181 (2014).","journal-title":"Microbiology"},{"key":"727_CR165","doi-asserted-by":"publisher","first-page":"e29726","DOI":"10.1371\/journal.pone.0029726","volume":"7","author":"M Arras","year":"2012","unstructured":"Arras, M. et al. Multiparameter telemetry as a sensitive screening method to detect vaccine reactogenicity in mice. PLoS ONE 7, e29726 (2012).","journal-title":"PLoS ONE"},{"key":"727_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56994-8","volume":"9","author":"J Weiner","year":"2019","unstructured":"Weiner, J. et al. Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium. Sci. Rep. 9, 20362 (2019).","journal-title":"Sci. Rep."},{"key":"727_CR167","doi-asserted-by":"publisher","first-page":"e96031","DOI":"10.1172\/jci.insight.96031","volume":"2","author":"CY Chan","year":"2017","unstructured":"Chan, C. Y. et al. Early molecular correlates of adverse events following yellow fever vaccination. JCI Insight 2, e96031 (2017).","journal-title":"JCI Insight"},{"key":"727_CR168","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.vaccine.2019.02.015","volume":"37","author":"W Burny","year":"2019","unstructured":"Burny, W. et al. Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans. Vaccine 37, 2004\u20132015 (2019).","journal-title":"Vaccine"},{"key":"727_CR169","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/21645515.2019.1697110","volume":"16","author":"P Gonzalez-Dias","year":"2020","unstructured":"Gonzalez-Dias, P. et al. Methods for predicting vaccine immunogenicity and reactogenicity. Hum. Vaccin. Immunother. 16, 269\u2013276 (2020).","journal-title":"Hum. Vaccin. Immunother."},{"key":"727_CR170","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1586\/14760584.2015.1081067","volume":"14","author":"L Zhang","year":"2015","unstructured":"Zhang, L., Wang, W. & Wang, S. Effect of vaccine administration modality on immunogenicity and efficacy. Expert Rev. Vaccines 14, 1509\u201323 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"727_CR171","unstructured":"Frieden, T. R. Public health then and now: celebrating 50 years of MMWR at CDC: foreward. (2011)."},{"key":"727_CR172","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/nm1213","volume":"11","author":"J Holmgren","year":"2005","unstructured":"Holmgren, J. & Czerkinsky, C. Mucosal immunity and vaccines. Nat. Med. 11, S45\u2013S53 (2005).","journal-title":"Nat. Med."},{"key":"727_CR173","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","volume":"55","author":"RC Mettelman","year":"2022","unstructured":"Mettelman, R. C., Allen, E. K. & Thomas, P. G. Mucosal immune responses to infection and vaccination in the respiratory tract. Immunity 55, 749\u2013780 (2022).","journal-title":"Immunity"},{"key":"727_CR174","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1128\/JVI.03101-13","volume":"88","author":"GE Price","year":"2014","unstructured":"Price, G. E. et al. Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model. J. Virol. 88, 6019\u20136030 (2014).","journal-title":"J. Virol."},{"key":"727_CR175","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1016\/j.vaccine.2019.08.041","volume":"37","author":"J Feng","year":"2019","unstructured":"Feng, J. et al. Enhanced protection against Q fever in BALB\/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation. Vaccine 37, 6076\u20136084 (2019).","journal-title":"Vaccine"},{"key":"727_CR176","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/eji.200738067","volume":"38","author":"M Benoit","year":"2008","unstructured":"Benoit, M. et al. Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages. Eur. J. Immunol. 38, 1065\u201370 (2008).","journal-title":"Eur. J. Immunol."},{"key":"727_CR177","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3390\/vaccines11030511","volume":"11","author":"SE Williams-Macdonald","year":"2023","unstructured":"Williams-Macdonald, S. E. et al. Efficacy of phase I and phase II Coxiella burnetii bacterin vaccines in a pregnant Ewe challenge model. Vaccines 11, 511 (2023).","journal-title":"Vaccines"},{"key":"727_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00607-z","volume":"8","author":"S Tomaiuolo","year":"2023","unstructured":"Tomaiuolo, S. et al. QuilA(R) adjuvanted Coxevac(R) sustains Th1-CD8(+)-type immunity and increases protection in Coxiella burnetii-challenged goats. npj Vaccines 8, 17 (2023).","journal-title":"npj Vaccines"},{"key":"727_CR179","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1128\/CVI.00119-08","volume":"15","author":"DM Waag","year":"2008","unstructured":"Waag, D. M. et al. Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii. Clin. Vaccin. Immunol. 15, 1505\u20131512 (2008).","journal-title":"Clin. Vaccin. Immunol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00727-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00727-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00727-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T03:04:38Z","timestamp":1700449478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00727-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":179,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["727"],"URL":"https:\/\/doi.org\/10.1038\/s41541-023-00727-6","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,7]]},"assertion":[{"value":"2 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}